Performance
Trailing returns
| 1 day | +1.36% |
| |||
| 1 week |
| -0.08% | |||
| 4 week |
| -5.61% | |||
| 3 month | +1.27% |
| |||
| YTD | +13.71% |
| |||
| 1 year | +32.81% |
| |||
| 3 years* | +11.21% |
| |||
| 5 years* | - | ||||
| *annualized | |||||
| Best 3 month return | +13.31% | |
| Worst 3 month return | -20.10% |
Morningstar statistics
Morningstar category: International Equity
| Return | Risk | Rating | |
| 3 years | High | Above Average |
|
| 5 years | - | - | - |
| 10 years | - | - | - |
| Overall | High | Above Average |
|
Morningstar style Learn more
| Large | |||
| Mid | |||
| Small | |||
| Value | Blend | Growth |
Key statistics
| Total assets | 42.00M | |
| Front load | - | |
| Deferred load | - | |
| Expense ratio | - | |
| Management fee | 1.90% | |
| Fund family | CI Investments Inc. |
Asset allocation
| Cash | 2.54% | |
| Stocks | 97.46% | |
| Bonds | 0.00% | |
| Other | 0.00% |
Purchase information
| Initial | $500 | |
| Additional | $50 | |
| IRA Initial | $50 | |
| AIP Initial | $50 | |
| AIP Additional | $50 |
11.94+0.27(2.31%)
Jun 17, 4:30PM EDT
Overall Morningstar RatingTM
Description
The primary investment objective of the fund is to provide long-term capital appreciation. This will be accomplished mainly through investments in a managed portfolio of diversified equity securities of international issuers, which are believed to offer above-average growth potential. Specifically, this Partner Fund may invest in issuers considered likely to benefit from rapidly growing segments of the world population. The management fee for this fund is negotiable. Please note: on the 7th anniversary and thereafter, units purchased under the DSC schedule will receive a trailer fee identical to the ISC trailer fee.
Asset managers:
David Picton (Started: Dec 1, 2010)
Michael Kuan (Started: Dec 1, 2010)
David Picton (Started: Dec 1, 2010)
Michael Kuan (Started: Dec 1, 2010)
Advisor Company:
Picton Mahoney Asset Management
Picton Mahoney Asset Management
Risk
| 1 year | 3 years | 5 years | 10 years | ||
| Alpha* | 19.18 | 1.79 | - | - | |
| Beta* | 0.39 | 1.02 | - | - | |
| Mean annual return | 2.56 | 1.10 | - | - | |
| R-squared* | 35.25 | 84.87 | - | - | |
| Standard deviation | 4.64 | 13.16 | - | - | |
| Sharpe ratio | 6.42 | 0.93 | - | - | |
| * Against standard index | |||||
Top 10 holdings
| Security | Net Assets | |
| Roche Holding AG (RHHVF) | 2.19% | |
| Sanofi (SAN) | 2.03% | |
| Coloplast (COLO B) | 1.67% | |
| Novo Nordisk A/S (NONOF) | 1.58% | |
| Volkswagen AG (VOW3) | 1.52% | |
| Capgemini (CAP) | 1.45% | |
| Continental AG (CON) | 1.42% | |
| Sumitomo Mitsui Financial Group Inc (SMFNF) | 1.40% | |
| Bertrandt AG (BDT) | 1.40% | |
| Lundin Petroleum AB (LNDNF) | 1.35% |